Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University

Other

Pipeline Programs↗

Distinct drugs in development (Preclinical–Phase 3)

Indications↗

Distinct diseases across all programs

113

Clinical Trials↗

All sponsored trials (all statuses)

Pipeline

Pipeline Snapshot

By Phase

1 drugs in development

Approved1

Phase 11

By Therapeutic Area

top 2

Gastroenterology

133%

Rare Disease

133%

R&D Momentum

27/100

Pipeline Velocity

0/100

Trial Completion Rate

70/100

Pipeline Concentration

33/100

Pipeline Freshness

0/100

Strategic Signals

↗Active in Gastroenterology but thin pipeline — potential licensing opportunity

Activity

Recent Activity

Last 14 days

Oct 31, 2026

Active, not recruiting

Phase I Trial of High Dose Rate Brachytherapy Combined With Stereotactic Body Radiation Therapy for Intermediate Risk Prostate Cancer Patients

Oct 23, 2026

Active, not recruiting

A Randomized Phase ll Study of Adjuvant Sunitinib or Valproic Acid in High-Risk Patients With Uveal Melanoma

Earlier

Oct 9, 2026TrialPhase II Randomized, Placebo-Controlled Trial of Linaclotide to Demonstrate Bioactivity in Patients With Sporadic Colorectal Adenomas and With Colorectal Cancer

Aug 19, 2026TrialPhase II, Single Arm, Open Label Multi-center Study of Obinutuzumab and Ibrutinib in the Front Line Treatment of Indolent Non-Hodgkin's Lymphomas

Jul 24, 2026TrialA 2 Step Approach to Matched Related Hematopoietic Stem Cell Transplantation for Patients With Hematological Malignancies-5+5 Dosing

Jul 17, 2026TrialPhase II Study of Adjuvant Nivolumab in Patients With Resected Stage IIB/IIC Melanoma

Jul 8, 2026TrialIpilimumab and Nivolumab in Combination With Immunoembolization for the Treatment of Metastatic Uveal Melanoma

Aug 9, 2019TrialStereotactic Body Radiation Therapy and Aflibercept in Treating Patients With Uveal Melanoma

4 more events

Dec 24, 2018TrialStereotactic Body Radiation Therapy With REGN2810 and/or Ipilimumab Before Surgery in Treating Participants With Progressive Advanced or Oligometastatic Prostate Cancer

Nov 1, 2018TrialDurvalumab With or Without Metformin in Treating Participants With Head and Neck Squamous Cell Carcinoma

Sep 6, 2018TrialContrast-Enhanced Ultrasound Identification of Sentinel Nodes in Esophageal Cancer

Aug 1, 2018TrialCPI-613 in Combination With Modified FOLFIRINOX in Patients With Locally Advanced Pancreatic Cancer

Details

Company Info

Company Overview

—

Mkt Cap

—

Revenue

—

Cash

Pipeline

Drug Pipeline

Indication

Preclinical

Phase 1

Phase 2

Phase 3

Approved

LinzessApproved

Irritable Bowel Syndrome

LinzessApproved

Rare Disease

SMA

LinzessPhase 1

Unknown / Other

Colorectal Adenoma

LinzessApproved

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)